348 related articles for article (PubMed ID: 16831667)
1. Bisphosphonate-associated osteonecrosis of the jaws. Report of a case and literature review.
Leite AF; Figueiredo PT; Melo NS; Acevedo AC; Cavalcanti MG; Paula LM; Paula AP; Guerra EN
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Jul; 102(1):14-21. PubMed ID: 16831667
[TBL] [Abstract][Full Text] [Related]
2. Bisphosphonate-induced osteonecrosis of the jaws: a case report and literature review.
Tsai WS; Haghighi K; Placa SJ
Gen Dent; 2006; 54(3):215-9; quiz 220-2. PubMed ID: 16776417
[TBL] [Abstract][Full Text] [Related]
3. Consequence of therapy discontinuation in bisphosphonate-associated osteonecrosis of the jaws.
Gallego L; Junquera L
Br J Oral Maxillofac Surg; 2009 Jan; 47(1):67-8. PubMed ID: 18639371
[TBL] [Abstract][Full Text] [Related]
4. Bisphosphonate-associated osteonecrosis of the jaws: a therapeutic dilemma.
Diego R; D'Orto O; Pagani D; Agazzi A; Marzano U; Derada Troletti G; Fontanella W; Pignataro L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):e1-5. PubMed ID: 17197204
[TBL] [Abstract][Full Text] [Related]
5. Bisphosphonate-associated osteonecrosis: a clinician's reference to patient management.
Grewal VS; Fayans EP
Todays FDA; 2008 Aug; 20(8):38-41, 43-6. PubMed ID: 18767452
[TBL] [Abstract][Full Text] [Related]
6. Osteonecrosis of the maxilla in a patient with a history of bisphosphonate therapy.
Melo MD; Obeid G
J Can Dent Assoc; 2005 Feb; 71(2):111-3. PubMed ID: 15691429
[TBL] [Abstract][Full Text] [Related]
7. Paget's disease and bisphosphonate-associated osteonecrosis of the jaws.
Gueiros LA; Lopes MA; Leão JC
J Oral Maxillofac Surg; 2008 Jun; 66(6):1319. PubMed ID: 18486809
[No Abstract] [Full Text] [Related]
8. Osteonecrosis of the jaws due to bisphosphonate use. A review of 60 cases and treatment proposals.
Magopoulos C; Karakinaris G; Telioudis Z; Vahtsevanos K; Dimitrakopoulos I; Antoniadis K; Delaroudis S
Am J Otolaryngol; 2007; 28(3):158-63. PubMed ID: 17499130
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate.
Walter C; Al-Nawas B; Grötz KA; Thomas C; Thüroff JW; Zinser V; Gamm H; Beck J; Wagner W
Eur Urol; 2008 Nov; 54(5):1066-72. PubMed ID: 18602738
[TBL] [Abstract][Full Text] [Related]
10. Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy.
Migliorati CA; Schubert MM; Peterson DE; Seneda LM
Cancer; 2005 Jul; 104(1):83-93. PubMed ID: 15929121
[TBL] [Abstract][Full Text] [Related]
11. Jaw bone necrosis without previous dental extractions associated with the use of bisphosphonates (pamidronate and zoledronate): a four-case report.
Merigo E; Manfredi M; Meleti M; Corradi D; Vescovi P
J Oral Pathol Med; 2005 Nov; 34(10):613-7. PubMed ID: 16202082
[TBL] [Abstract][Full Text] [Related]
12. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
[TBL] [Abstract][Full Text] [Related]
13. Bisphosphonate-induced avascular osteonecrosis of the jaws: a clinical report of 11 cases.
Dimitrakopoulos I; Magopoulos C; Karakasis D
Int J Oral Maxillofac Surg; 2006 Jul; 35(7):588-93. PubMed ID: 16687238
[TBL] [Abstract][Full Text] [Related]
14. Sore mandible. Bisphosphonate-associated osteonecrosis.
Damm DD; Fantasia JE
Gen Dent; 2006; 54(5):370, 372. PubMed ID: 17004575
[No Abstract] [Full Text] [Related]
15. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment.
Marx RE; Sawatari Y; Fortin M; Broumand V
J Oral Maxillofac Surg; 2005 Nov; 63(11):1567-75. PubMed ID: 16243172
[TBL] [Abstract][Full Text] [Related]
16. Clinical aspects and management of bisphosphonates-associated osteonecrosis of the jaws.
Biasotto M; Chiandussi S; Dore F; Rinaldi A; Rizzardi C; Cavalli F; Di Lenarda R
Acta Odontol Scand; 2006 Nov; 64(6):348-54. PubMed ID: 17123911
[TBL] [Abstract][Full Text] [Related]
17. Recurrent low-energy femoral shaft fractures and osteonecrosis of the jaw in a case of multiple myeloma treated with bisphosphonates.
Grasko JM; Herrmann RP; Vasikaran SD
J Oral Maxillofac Surg; 2009 Mar; 67(3):645-9. PubMed ID: 19231794
[No Abstract] [Full Text] [Related]
18. Association of osteonecrosis of the jaws and bisphosphonate pharmacotherapy: dental implications.
Hay KD; Bishop PA
N Z Dent J; 2006 Mar; 102(1):4-9. PubMed ID: 16568881
[TBL] [Abstract][Full Text] [Related]
19. Bisphosphonate-associated osteonecrosis. A clinician's reference to patient management.
Grewal VS; Fayans EP
N Y State Dent J; 2008 Jan; 74(1):38-44. PubMed ID: 18402375
[TBL] [Abstract][Full Text] [Related]
20. Bisphosphonate-associated osteonecrosis of the jaw: the rheumatologist's role.
Capsoni F; Longhi M; Weinstein R
Arthritis Res Ther; 2006; 8(5):219. PubMed ID: 17049069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]